Christopher G. Azzoli
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.2%
- Molecular Biology top 5%
- Cancer Research top 1%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Mark G. KrisJohn R. StrawnWilliam PaoSherman BakerThomas J. SmithVincent A. MillerLee M. KrugNaiyer A. Rizvi
- Topics
- Lung Cancer Treatments and Mutations (100 papers)Lung Cancer Research Studies (54 papers)Lung Cancer Diagnosis and Treatment (51 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Christopher G. Azzoli
150 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Pulmonary and Respiratory Medicine 7.5k
- Oncology 6.0k
- Molecular Biology 2.4k
- Cancer Research 1.4k
- Radiology, Nuclear Medicine and Imaging 1.1k
Countries citing papers authored by Christopher G. Azzoli
This map shows the geographic impact of Christopher G. Azzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher G. Azzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher G. Azzoli more than expected).
Fields of papers citing papers by Christopher G. Azzoli
This network shows the impact of papers produced by Christopher G. Azzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher G. Azzoli. The network helps show where Christopher G. Azzoli may publish in the future.
Co-authorship network of co-authors of Christopher G. Azzoli
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher G. Azzoli. A scholar is included among the top collaborators of Christopher G. Azzoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher G. Azzoli. Christopher G. Azzoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 137 | |
| 2 | 4 | |
| 3 | 18 | |
| 4 | 44 | |
| 5 | 64 | |
| 6 | 176 | |
| 7 | 266 | |
| 8 | 122 | |
| 9 | 99 | |
| 10 | 50 | |
| 11 | 13 | |
| 12 | 68 | |
| 13 | 70 | |
| 14 | 101 | |
| 15 | 74 | |
| 16 | American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancerbreakdown → | 752 |
| 17 | 202 | |
| 18 | Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC) | 1 |
| 19 | 11 | |
| 20 | 2 |
About Christopher G. Azzoli
Christopher G. Azzoli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 154 papers that have together received 10.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (100 papers), Lung Cancer Research Studies (54 papers) and Lung Cancer Diagnosis and Treatment (51 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.5k citations), Oncology (6.0k citations) and Cancer Research (1.4k citations). Christopher G. Azzoli has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Mark G. Kris, John R. Strawn, William Pao, Sherman Baker, Thomas J. Smith, Vincent A. Miller, Lee M. Krug, Naiyer A. Rizvi, David G. Pfister and Sarah Temin. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.